Xvivo Perfusion AB (publ) XVIPF
XVIPF
Xvivo Perfusion AB (publ) CALZF
PolyNovo Limited FDMDF
4DMedical Limited CLVSF
CellaVision AB (publ) LBLTF
Lattice Biologics Ltd. SWDCF
Swedencare AB (publ) VBIZF
Viva Biotech Holdings AVNBF
Avon Technologies Plc BJTRF
Beijing Tong Ren Tang Chinese Medicine Company Limited SOLTF
Nxera Pharma Co., Ltd.
Xvivo Perfusion AB (publ) CALZF
PolyNovo Limited FDMDF
4DMedical Limited CLVSF
CellaVision AB (publ) LBLTF
Lattice Biologics Ltd. SWDCF
Swedencare AB (publ) VBIZF
Viva Biotech Holdings AVNBF
Avon Technologies Plc BJTRF
Beijing Tong Ren Tang Chinese Medicine Company Limited SOLTF
Nxera Pharma Co., Ltd.
Performance
| Periode | XVIPF | CALZF | FDMDF | CLVSF | LBLTF | SWDCF | VBIZF | AVNBF | BJTRF | SOLTF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -38.89 % | 6.25 % | 931.15 % | 21.01 % | 0.00 % | -2.93 % | 21.90 % | -27.19 % | -1.26 % | -20.43 % |
| YTD | -51.08 % | -18.27 % | 591.18 % | -9.96 % | 0.00 % | -7.44 % | 316.08 % | -3.45 % | -1.26 % | -9.58 % |
| 1Y | -51.08 % | -32.00 % | 591.18 % | -9.96 % | 0.00 % | -7.44 % | 159.68 % | 5.26 % | -1.26 % | -9.58 % |
| 3Y | -2.17 % | -28.57 % | 539.11 % | 3.87 % | 0.00 % | 30.92 % | 23.74 % | 34.61 % | -57.03 % | -50.97 % |
| 5Y | -28.20 % | -70.69 % | 43.29 % | -23.86 % | -99.68 % | -69.36 % | -70.50 % | -67.53 % | -57.03 % | -64.72 % |
| 10Y | 232.31 % | 385.71 % | 43.29 % | 253.48 % | -99.78 % | -69.36 % | -47.79 % | 2.44 % | -57.03 % | -72.08 % |
| From the beginning | 243.68 % | 183.33 % | 43.29 % | 1 181.87 % | -100.00 % | -69.36 % | -47.79 % | 827.37 % | -57.03 % | -47.65 % |